This presentation was given by ESI at the SHAC In-Person Meeting hosted on October 25th in Philadelphia, PA. This PowerPoint presentation provides an overview of PBM Transparency. This presentation summarizes the historical agenda of PBM Transparency as related to ADF Opioids, Uniform Prior Authorization Forms as well as the Prohibition of Step Therapy (Prescriber Prevails). In 2017, PBM Transparency appeared within  High Cost Drugs, Frozen Formulary and Anti-Step Therapy legislation. Overall, ‘PBM Transparency has been a “go to” for industry opponents for more than a decade.’